LAUSR

Liraglutide inhibits gallstone formation.

Sign Up to like & get
recommendations!
0 Published in 2021 at "Metabolism: clinical and experimental"

DOI: 10.1016/j.metabol.2021.154728

Abstract: BACKGROUND & AIMS Cholesterol gallstone disease (CGD) is a common gastrointestinal disease. Liraglutide, an analog of glucagon-like peptide 1, has been approved to treat type 2 diabetes. Clinical studies have suggested a potential role of… read more here.

Keywords: fxr; cgd; cholesterol; liraglutide ... See more keywords